Literature DB >> 25638290

Mitochondrial pathology in inclusion body myositis.

Ulrika Lindgren1, Sara Roos1, Carola Hedberg Oldfors1, Ali-Reza Moslemi1, Christopher Lindberg2, Anders Oldfors3.   

Abstract

Inclusion body myositis (IBM) is usually associated with a large number of cytochrome c oxidase (COX)-deficient muscle fibers and acquired mitochondrial DNA (mtDNA) deletions. We studied the number of COX-deficient fibers and the amount of mtDNA deletions, and if variants in nuclear genes involved in mtDNA maintenance may contribute to the occurrence of mtDNA deletions in IBM muscle. Twenty-six IBM patients were included. COX-deficient fibers were assayed by morphometry and mtDNA deletions by qPCR. POLG was analyzed in all patients by Sanger sequencing and C10orf2 (Twinkle), DNA2, MGME1, OPA1, POLG2, RRM2B, SLC25A4 and TYMP in six patients by next generation sequencing. Patients with many COX-deficient muscle fibers had a significantly higher proportion of mtDNA deletions than patients with few COX-deficient fibers. We found previously unreported variants in POLG and C10orf2 and IBM patients had a significantly higher frequency of an RRM2B variant than controls. POLG variants appeared more common in IBM patients with many COX-deficient fibers, but the difference was not statistically significant. We conclude that COX-deficient fibers in inclusion body myositis are associated with multiple mtDNA deletions. In IBM patients we found novel and also previously reported variants in genes of importance for mtDNA maintenance that warrants further studies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytochrome c oxidase deficiency; Inclusion body myositis; Mitochondrial DNA; mtDNA

Mesh:

Substances:

Year:  2015        PMID: 25638290     DOI: 10.1016/j.nmd.2014.12.010

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

Review 1.  Inclusion body myositis and associated diseases: an argument for shared immune pathologies.

Authors:  Christopher Nelke; Felix Kleefeld; Corinna Preusse; Tobias Ruck; Werner Stenzel
Journal:  Acta Neuropathol Commun       Date:  2022-06-03       Impact factor: 7.578

Review 2.  Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.

Authors:  George K Papadimas; Charalampos Kokkinis; Sophia Xirou; Margarita Chrysanthou; Evangelia Kararizou; Constantinos Papadopoulos
Journal:  Rheumatol Int       Date:  2019-05-04       Impact factor: 2.631

Review 3.  New Developments in the Genetics of Inclusion Body Myositis.

Authors:  Kyla A Britson; Stephanie Y Yang; Thomas E Lloyd
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

Review 4.  Genetics in inclusion body myositis.

Authors:  Simon Rothwell; James B Lilleker; Janine A Lamb
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

Review 5.  Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras.

Authors:  Boel De Paepe
Journal:  Biomolecules       Date:  2019-01-07

6.  De Novo Development of mtDNA Deletion Due to Decreased POLG and SSBP1 Expression in Humans.

Authors:  Yeonmi Lee; Taeho Kim; Miju Lee; Seongjun So; Mustafa Zafer Karagozlu; Go Hun Seo; In Hee Choi; Peter C W Lee; Chong-Jai Kim; Eunju Kang; Beom Hee Lee
Journal:  Genes (Basel)       Date:  2021-02-17       Impact factor: 4.096

7.  Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis.

Authors:  Ulrika Lindgren; Rille Pullerits; Christopher Lindberg; Anders Oldfors
Journal:  Ann Neurol       Date:  2022-06-06       Impact factor: 11.274

8.  Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis.

Authors:  Karolina A Rygiel; Helen A Tuppen; John P Grady; Amy Vincent; Emma L Blakely; Amy K Reeve; Robert W Taylor; Martin Picard; James Miller; Doug M Turnbull
Journal:  Nucleic Acids Res       Date:  2016-04-30       Impact factor: 16.971

9.  Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.

Authors:  Carola Hedberg-Oldfors; Ulrika Lindgren; Swaraj Basu; Kittichate Visuttijai; Christopher Lindberg; Maria Falkenberg; Erik Larsson Lekholm; Anders Oldfors
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

10.  Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis.

Authors:  Chiseko Ikenaga; Hidetoshi Date; Motoi Kanagawa; Jun Mitsui; Hiroyuki Ishiura; Jun Yoshimura; Iago Pinal-Fernandez; Andrew L Mammen; Thomas E Lloyd; Shoji Tsuji; Jun Shimizu; Tatsushi Toda; Jun Goto
Journal:  Ann Neurol       Date:  2022-02-11       Impact factor: 11.274

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.